Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000903423-16-001017
Filing Date
2016-05-11
Accepted
2016-05-11 09:17:51
Documents
3

Document Format Files

Seq Description Document Type Size
1 wildcat13da3.htm SC 13D/A 148728
2 exhibit5.htm EX-5 19941
3 GRAPHIC image_007.jpg GRAPHIC 13249
  Complete submission text file 0000903423-16-001017.txt   188618
Mailing Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121
Business Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Subject) CIK: 0000850261 (see all company filings)

EIN.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82540 | Film No.: 161638241
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 888 SEVENTH AVENUE NEW YORK NY 10106
Business Address 888 SEVENTH AVENUE NEW YORK NY 10106 212-468-5100
Wildcat Capital Management, LLC (Filed by) CIK: 0001582384 (see all company filings)

EIN.: 453715536 | State of Incorp.: DE | Fiscal Year End: 1213
Type: SC 13D/A